Vaginal microbiota impacts of a Lactobacillus crispatus live biotherapeutic and predictors of colonization in randomized controlled trial
Cell Host & Microbe · 2026-04 · 34 (4) · 734-750.e10
DOI: 10.1016/j.chom.2026.03.003 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cell Host & Microbe, 2026-04. Verfasst von Seth M Bloom und 14 weiteren Autor:innen. Beteiligte Einrichtung: Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA; Infectious Diseases Division, Massachusetts General Hospital, Bo…. Hauptthemen laut MEDLINE: Vaginosis, Bacterial, Vagina, Lactobacillus crispatus, Microbiota. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Bill & Melinda Gates Foundation, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Bacterial vaginosis (BV) affects >25% of women worldwide and often recurs after standard-of-care metronidazole (MTZ) treatment. LACTIN-V, a live biotherapeutic product (LBP) containing Lactobacillus crispatus strain CTV-05, significantly reduced recurrent BV in a phase 2b clinical trial, but efficacy was incomplete. Here, we characterize microbiota and immune effects using multi-omics and define correlates of treatment success. By week 12, an L. crispatus-dominant microbiota was achieved in 30% of LBP recipients compared with 9% of placebo recipients (benefit ratio: 3.31; p < 0.005). This is primarily due to CTV-05, but native L. crispatus strains are also present and increase over time. Inflammatory cytokines decrease in both arms after MTZ but return to baseline in placebo recipients. Successful L. crispatus colonization is associated with pre-MTZ microbiota, baseline inflammatory profiles, post-MTZ bacterial load, and clinical and behavioral variables. These findings elucidate LBP microbiota effects and identify predictors of treatment success, informing improved intervention strategies to advance women's health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA; Infectious Diseases Division, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA.
- Institute of Statistics, Biostatistics and Actuarial Sciences, Louvain Institute of Data Analysis and Modelling, UCLouvain, 1348 Louvain-la-Neuve, Belgium.
- Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.
- Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA; Harvard Medical School, Boston, MA 02115, USA; Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA 02114…
- Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94158, USA.
- Osel, Inc., Mountain View, CA 94043, USA.
Förderung
- Bill & Melinda Gates Foundation
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Gates Foundation
Zitieren
APA
Bloom, S. M., Symul, L., Elsherbini, J., Xu, J., Hussain, S., Shih, J., Sango, A., Mitchell, C. M., Hemmerling, A., Parks, T. P., Kannan, A., Hussain, F. A., Cohen, C. R., Holmes, S. P., & Kwon, D. S. (2026). Vaginal microbiota impacts of a Lactobacillus crispatus live biotherapeutic and predictors of colonization in randomized controlled trial. Cell Host & Microbe, 34(4), 734-750.e10. https://doi.org/10.1016/j.chom.2026.03.003
Vancouver
Bloom SM, Symul L, Elsherbini J, Xu J, Hussain S, Shih J, et al. Vaginal microbiota impacts of a Lactobacillus crispatus live biotherapeutic and predictors of colonization in randomized controlled trial. Cell Host & Microbe. 2026;34(4):734-750.e10. doi:10.1016/j.chom.2026.03.003
BibTeX
@article{Bloom2026,
author = {Bloom, Seth M and Symul, Laura and Elsherbini, Joseph and Xu, Jiawu and Hussain, Salina and Shih, Johnathan and Sango, Ashley and Mitchell, Caroline M and Hemmerling, Anke and Parks, Thomas P and Kannan, Aditi and Hussain, Fatima A and Cohen, Craig R and Holmes, Susan P and Kwon, Douglas S},
title = {Vaginal microbiota impacts of a Lactobacillus crispatus live biotherapeutic and predictors of colonization in randomized controlled trial},
journal = {Cell Host & Microbe},
year = {2026},
volume = {34},
number = {4},
pages = {734--750.e10},
doi = {10.1016/j.chom.2026.03.003}
}
EUVIMED